Head-to-head · Cost-Efficiency Index
Oak vs MyDrHank
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Oak
Shoppers willing to complete a long health intake before they see a price, who want the non-injectable route on the same account as the two weekly injections and will confirm the number Oak quotes them rather than the one on its homepage.
Visit OakMyDrHank
Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.
Visit MyDrHankThe verdict
Oak and MyDrHank tie on the Cost-Efficiency Index at 65/100, so neither wins outright on the numbers. For most shoppers we'd start with Oak (ranked #129, a hair above #130) — Shoppers willing to complete a long health intake before they see a price, who want the non-injectable route on the same account as the two weekly injections and will confirm the number Oak quotes them rather than the one on its homepage. But MyDrHank is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Oak.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Oak | MyDrHank |
|---|---|---|
| Cost-Efficiency Index | 65/100 | 65/100 |
| Semaglutide / mo | $250/mo (one flat rate at every dose), read on its order form the afternoon of 15 August — fifty dollars higher than that morning | $249/mo oral, $259/mo injectable (yearly prepay: $171 / $178) |
| Tirzepatide / mo | $300/mo (one flat rate at every dose), read on its order form the afternoon of 15 August — fifty dollars higher than that morning | $349/mo month-to-month ($240/mo only on a year prepaid) |
| Semaglutide / yr (modeled) | — | $2,988 |
| Tirzepatide / yr (modeled) | — | $4,188 |
| Coverage | 45 states (list not published) | Not published; program excludes KS, LA, MS, NM, ND, WV |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #129 | #130 |
Oak
65/100Where the value is
- A non-injectable route alongside the two weekly injections — sublingual drops or tablets targeting the GLP-1 pathway — which most programs at this end of the ranking do not offer at all
- LegitScript-certified, provider-reviewed, no video call required, with free shipping and free health coaching included
- Its own comparison tables do print undiscounted floors — $167/mo on the homepage, $190/mo on /weight-loss — so a reader who scrolls past the hero at least sees figures that are not a package discount in a monthly slot
The tradeoffs
- It publishes NINE different "starting" prices — $119, $133, $160, $167, $180, $185, $190, $199 and $250 — and attaches a term, a plan length or a billing cadence to not one of them
- The $119 and $185 in the homepage hero appear only beside a "$200 off — new patient offer", and Oak's own affiliate page defines that offer as "$50 off your first month, $200 off 3-months" — a three-month package discount presented as a monthly rate
MyDrHank
65/100Where the value is
- The price does not change as your dose is titrated up — its FAQ states it plainly ("The price stays the same at every dose — no surprise price increases"), and dose-indexed pricing is the single most common way a cheap first month becomes an expensive fourth one
- A genuine oral route on semaglutide: a daily tablet, including one compounded with low-dose ondansetron specifically to blunt the nausea that ends most GLP-1 courses early
- The entire price ladder is public — monthly, quarterly, 6-month and yearly, with the total for each term printed beside the per-month figure — before any quiz, intake or email capture
The tradeoffs
- EVERY price the site advertises is a twelve-month prepay rate, and not by accident: the price display is coded to return the cheapest term in the ladder, so "From $X/mo" is always the yearly figure. No page shows a month-to-month rate beside it
- What the twelve months actually cost, up front: oral semaglutide $2,057 to reach the advertised $171/mo, injectable semaglutide $2,140 to reach $178/mo, and tirzepatide $2,883 to reach $240/mo
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.